Page last updated: 2024-10-31

moxisylyte and Urethral Diseases

moxisylyte has been researched along with Urethral Diseases in 1 studies

Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)

Urethral Diseases: Pathological processes involving the URETHRA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Combes, T1
Beguin, AM1
Coulomb, Y1
Barouti, H1
Costa, P1

Other Studies

1 other study available for moxisylyte and Urethral Diseases

ArticleYear
[Changes in urethral pressure after intravenous injection of moxisylyte hydrochloride in urethral instability in women. Preliminary results].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 1995, Volume: 5, Issue:1

    Topics: Adult; Female; Humans; Injections, Intravenous; Middle Aged; Moxisylyte; Placebos; Polyuria; Pressur

1995